OpenEvidence Stock
| Valuation | $12.19B1 |
| Valuation Date | Apr 14, 2026 |
| Implied Valuation | $11.89B |
| Last Price | $474.08 |
| 52-Week High | $499.08 |
| 52-Week Low | $155.70 |
| YTD Return | +85.81% |
| 1-Year Return | +204.48% |
| 3-Year Return | n/a |
| Total Funding | $700M2 |
| Latest Round Amount | $250M3 |
| Latest Round | Series D-2 |
| Funding Rounds | n/a |
| IPO Status | Unknown |
| Expected IPO Date | n/a |
| Revenue | $100M4 |
| Revenue Type | Run Rate |
| P/S Ratio | 121.9 |
About OpenEvidence
OpenEvidence is an artificial intelligence company that operates a medical search engine for doctors. Physicians ask clinical questions in plain language and get answers with citations from peer-reviewed medical journals. The platform has content partnerships with the New England Journal of Medicine and The Journal of the American Medical Association. Access is free for verified clinicians. The company says its search engine is used daily by more than 40% of US physicians. OpenEvidence makes money by showing advertising from pharmaceutical companies while answers are generated. The company was founded in 2021 by Daniel Nadler and Zachary Ziegler and is headquartered in Miami, Florida.
Invest in OpenEvidence
OpenEvidence is a private company, so you can't purchase it with a regular brokerage account. However, its shares are available on Hiive.
Hiive is a secondary marketplace where accredited investors can buy and sell shares of private, pre-IPO companies. Invest in the world's most exciting startups before they go public.
Invest on HiiveStock Analysis may be compensated for user sign-ups through Hiive links. Hiive is not affiliated with Stock Analysis. Securities offered by Hiive Markets Limited, member of FINRA/SIPC.
News
American Medical Society for Sports Medicine and OpenEvidence Announce Partnership to Bring AI-Powered Sports Medicine Resources to Clinicians and Patients
MIAMI & LEAWOOD, Kan.--(BUSINESS WIRE)-- #clinicalai--The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence today announced a partnership that will focus on co-developing AI-powere...
OneOncology and OpenEvidence Partner to Improve Cancer Care Nationwide
MIAMI & NASHVILLE, Tenn.--(BUSINESS WIRE)-- #Oncology--OpenEvidence, the most widely used AI-powered medical search and clinical decision-support platform, and OneOncology, a physician-led national pl...
Springer Nature and OpenEvidence Announce Agreement to Maximise Exposure of Trusted Findings On OpenEvidence Platform
NEW YORK & MIAMI--(BUSINESS WIRE)-- #OpenEvidence--Springer Nature and OpenEvidence today announced a subscription agreement that brings peer-reviewed content from Springer Nature into OpenEvidence, w...
Los Angeles County Department of Public Health and OpenEvidence Partner to Connect Physicians With Local Public Health Guidance
MIAMI & LOS ANGELES--(BUSINESS WIRE)-- #ClinicalAI--The Los Angeles County Department of Public Health (DPH) and OpenEvidence, an AI-powered clinical decision support platform, today announced a colla...
Medical AI Startup OpenEvidence Weighs $200 Million Funding Round
Medical-focused artificial intelligence startup OpenEvidence has reportedly considered raising $200 million at a $20 billion valuation. However, the company is unlikely to proceed, partly because the ...
Boston Children's Hospital and OpenEvidence Collaborate to Advance AI-Powered Analysis of Clinical Practice Patterns
MIAMI & BOSTON--(BUSINESS WIRE)-- #medicalAI--Boston Children's Hospital, one of the nation's top pediatric hospitals, and OpenEvidence, the leading AI-powered clinical decision support platform, toda...
Doximity Outranks OpenEvidence, Frontier Models in Independent Stanford-Harvard Study of Clinical AI Safety
SAN FRANCISCO--(BUSINESS WIRE)--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Doximity Ask, its HIPAA-compliant clinical AI platform, o...
American Academy of Pediatrics and OpenEvidence Announce Collaboration to Improve Pediatric Care
MIAMI & ITASCA, Ill.--(BUSINESS WIRE)--Clinicians caring for children to benefit from evidence-based recommendations from AAP being incorporated into responses on the OpenEvidence platform.
Pathway Labs Announces World's First FDA Clearance for Multicondition AI in Cardiology and Partnership with OpenEvidence
NEW YORK--(BUSINESS WIRE)--Pathway Labs today announced its public launch of EchoNext, the world's first FDA-approved AI detection tool that reads standard 12-lead electrocardiograms (ECGs) to flag hi...
SNO and OpenEvidence Launch Official Generative AI Partnership
MIAMI & HOUSTON--(BUSINESS WIRE)--The Society for Neuro-Oncology (SNO), the world's largest multidisciplinary organization dedicated to advancing research, education, and clinical care for patients wi...
OpenEvidence and the American Academy of Ophthalmology Partner to Close the Gap Between Evidence and Eye Care
MIAMI & SAN FRANCISCO--(BUSINESS WIRE)-- #ClinicalAI--The American Academy of Ophthalmology, the world's largest association of eye physicians and surgeons, and OpenEvidence, the most widely used medi...
OpenEvidence Integrates ASCO Guidelines, Figures and Flowcharts into Specialty Oncology Model
MIAMI--(BUSINESS WIRE)-- #ASCO--Today, OpenEvidence, the most widely used medical knowledge platform, announced an integration of ASCO Guidelines, figures, and flowcharts into the OpenEvidence model. ...
OpenEvidence Launches Voice Mode: The First Native Speech-to-Speech Medical AI
MIAMI--(BUSINESS WIRE)-- #clinicalai--OpenEvidence, the most widely used medical AI platform among U.S. physicians, today launched Voice Mode, the first native speech-to-speech medical AI interface. W...
OpenEvidence and Society of Surgical Oncology Announce Strategic Partnership to Advance Surgical Cancer Care and Launch SSO Innovator Grant
MIAMI & ROSEMONT, Ill.--(BUSINESS WIRE)-- #MedicalAI--Today, the Society of Surgical Oncology (SSO), a global professional society for cancer surgeons, and OpenEvidence, the most widely used medical k...
The Global Initiative for Asthma and OpenEvidence Partner to Deliver Asthma Strategy to Physicians Worldwide
FONTANA, Wis. & MIAMI--(BUSINESS WIRE)-- #Asthma--The Global Initiative for Asthma (GINA) collaborates with OpenEvidence to make GINA's evidence-based asthma strategy reports, clinical recommendations...
OpenEvidence and ACOG Announce Strategic Collaboration to Advance Ob-Gyn Health Care
MIAMI & WASHINGTON--(BUSINESS WIRE)--Today, OpenEvidence and American College of Obstetricians & Gynecologists (ACOG) announced a strategic collaboration to expand access to ACOG's evidence-based clin...
AUA and OpenEvidence Collaborate to Expand Access to Evidence-Based Urologic Clinical Practice Guidelines
MIAMI & BALTIMORE--(BUSINESS WIRE)-- #AUA--The American Urological Association (AUA) and OpenEvidence, a leading AI-powered clinical decision support platform, today announced a new multi-year collabo...
OpenEvidence Collaborates With NCCN to Integrate Canonical Oncology Treatment Algorithms at the Point-of-Care
MIAMI--(BUSINESS WIRE)-- #MedicalAI--OpenEvidence now integrates National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) directly in answers, groundi...
Wiley and OpenEvidence Partner to Deliver Trusted Research to Physicians at the Point of Care
HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and O...
OpenEvidence and Veeva Announce Open Vista Partnership
PLEASANTON, Calif. and MIAMI , Oct. 16, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and OpenEvidence today announced the formation of a long-term partnership to jointly create and market Open Vist...